You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API acetaminophen, aspirin (nsaid) and caffeine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing acetaminophen, aspirin (nsaid) and caffeine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 BENZOIC ACID
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 CARNAUBA WAX
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 CELLULOSE, MICROCRYSTALLINE
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 FD&C BLUE NO. 1
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 HYDROXYPROPYL CELLULOSE
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC EXCEDRIN acetaminophen, aspirin (nsaid) and caffeine 0067-2039 HYPROMELLOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for acetaminophen, aspirin (nsaid) and caffeine

Excipient focus: BENZOIC ACID

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

acetaminophen, aspirin (nsaid) and caffeine drug variants containing CELLULOSE, MICROCRYSTALLINE

Glossary
Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-2039
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-8201
State of Florida DOH Central Pharmacy acetaminophen, aspirin (nsaid) and caffeine 53808-0835
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CROSPOVIDONE

Excipient focus: FD&C BLUE NO. 1

acetaminophen, aspirin (nsaid) and caffeine drug variants containing FD&C BLUE NO. 1

Glossary
Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-2039
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-8201
State of Florida DOH Central Pharmacy acetaminophen, aspirin (nsaid) and caffeine 53808-0835
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: LIGHT MINERAL OIL

Excipient focus: POLYSORBATE 20

Excipient focus: POVIDONE

Excipient focus: PROPYLENE GLYCOL

acetaminophen, aspirin (nsaid) and caffeine drug variants containing PROPYLENE GLYCOL

Glossary
Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-2039
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-8201
State of Florida DOH Central Pharmacy acetaminophen, aspirin (nsaid) and caffeine 53808-0835
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SACCHARIN SODIUM

Excipient focus: SORBITAN MONOLAURATE

Excipient focus: STEARIC ACID

Excipient focus: TITANIUM DIOXIDE

acetaminophen, aspirin (nsaid) and caffeine drug variants containing TITANIUM DIOXIDE

Glossary
Company Ingredient NDC
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-2039
GlaxoSmithKline Consumer Healthcare Holdings (US) LLC acetaminophen, aspirin (nsaid) and caffeine 0067-8201
State of Florida DOH Central Pharmacy acetaminophen, aspirin (nsaid) and caffeine 53808-0835
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group